$5.61-0.26 (-4.43%)
Strata Critical Medical, Inc.
Strata Critical Medical, Inc. in the Healthcare sector is trading at $5.61. Wall Street consensus targets $9.25 (4 analysts), implying a +64.9% move over the next 12 months. The stock is currently 14% below its 52-week high of $6.50, remaining 14.5% above its 200-day moving average. On fundamentals, Piotroski 4/9 shows mixed financial quality, Altman Z in the distress zone. The Whystock Score of 85/100 reflects bullish alignment across trend, valuation and analyst targets.
Simplified model based on P/E and ROE. Not a substitute for full valuation analysis. Data may be delayed. See our Terms.
Strata Critical Medical, Inc. provides time-critical logistics and medical services to the healthcare industry in the United States. It operates in two segments, Logistics and Clinical. The company offers logistics services, such as air and ground tr...
Strata Critical Medical is back in focus after an updated fair value estimate of $9.13, up from $8.81, reset expectations around what the stock might be worth on a modeled basis. That change comes alongside fresh Street commentary, where several firms have launched bullish coverage and one has lifted its price target by $0.25, tying their views to revised growth and profitability assumptions. As you read on, you will see how these shifting targets and narratives could shape how you follow...
Investors in Strata Critical Medical, Inc. ( NASDAQ:SRTA ) had a good week, as its shares rose 6.4% to close at US$5.34...
Joby Aviation reported better-than-expected first-quarter sales. Joby is still, essentially, presales. Joby stock gained 21% to $10.52 on Wednesday, while the and rose 1.5% and 1.2%, respectively.
Moby summary of Strata Critical Medical, Inc.'s Q1 2026 earnings call
Mathew Schneider: Thank you for standing by, and welcome to Strata's conference call and webcast for the quarter ended March 31, 2026. Before we get started, I would like to remind you of the company's forward-looking statement and safe harbor language. Statements made in this conference call that are not historical facts, including statements about future time periods, may be deemed to constitute forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995.